- Recommendation ID
- IPG637/1
- Question
Further research on platelet-rich plasma injections for knee osteoarthritis should be in the form of randomised controlled trials with medium- to long-term follow-up, including validated measures of knee function and patient-reported outcomes.
- Any explanatory notes
(if applicable) Current evidence on platelet-rich plasma injections for knee osteoarthritis raises no major safety concerns. However, the evidence on efficacy is limited in quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research.
Source guidance details
- Comes from guidance
- Platelet-rich plasma injections for knee osteoarthritis
- Number
- IPG637
- Date issued
- January 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/01/2019 |